S100B – a potential biomarker for early detection of neonatal brain damage following asphyxia

References

• Wilkinson D. The window of opportunity for treatment withdrawal. Arch Pediatr Adolesc Med 2011;165:211–215.
   PubMedGoogle Scholar
• Gazzolo D, Abella R, Marinoni E, di Iorio R, Li Volti G, Galvano F, Frigiola A et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22 Suppl 3:57–61.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G et al. Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury. Cardiovasc Hematol Agents Med Chem 2009;7:108–126.
   PubMedGoogle Scholar
• Gluckman PD, Pinal CS, Gunn AJ. Hypoxic-ischemic brain injury in the newborn: pathophysiology and potential strategies for intervention. Semin Neonatol 2001;6:109–120.
   PubMedGoogle Scholar
• Pin TW, Eldridge B, Galea MP. A review of developmental outcomes of term infants with post-asphyxia neonatal encephalopathy. Eur J Paediatr Neurol 2009;13:224–234.
   PubMed Web of Science ®Google Scholar
• Fatemi A, Wilson MA, Johnston MV. Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol 2009;36:835–58, vii.
   PubMed Web of Science ®Google Scholar
• Vannucci RC. Hypoxic-ischemic encephalopathy. Am J Perinatol 2000;17:113–120.
   PubMed Web of Science ®Google Scholar
• Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976;33:696–705.
   PubMed Web of Science ®Google Scholar
• Committee on Fetus and Newborn, AAoP, Committee on Obstetric Practice ACoO, and Gynecologists. Use and abuse of the Apgar Score. Pediatrics 1996;98:141–142.
   PubMed Web of Science ®Google Scholar
• MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319:1054–1059.
   PubMed Web of Science ®Google Scholar
• Hankins GD, Erickson K, Zinberg S, Schulkin J. Neonatal encephalopathy and cerebral palsy: a knowledge survey of Fellows of The American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;101:11–17.
   PubMed Web of Science ®Google Scholar
• Hnatyszyn G, Cyrylowski L, Czeszynska MB, Walecka A, Konefal H, Szmigiel O, Gizewska M, Dawid G. The role of magnetic resonance imaging in early prediction of cerebral palsy. Turk J Pediatr 2010;52:278–284.
   PubMed Web of Science ®Google Scholar
• Alderliesten T, de Vries LS, Benders MJNL, Koopman C, Groenendaal F. MR imaging and outcome of term neonates with perinatal asphyxia: value of diffusion-weighted MR imaging and 1H MR spectroscopy. Radiology 2011;261:235–242.
   PubMed Web of Science ®Google Scholar
• Bracci R, Perrone S, Buonocore G. The timing of neonatal brain damage. Biol Neonate 2006;90:145–155.
   PubMedGoogle Scholar
• Michetti F, Gazzolo D. S100B testing in pregnancy. Clin Chim Acta 2003;335:1–7.
   PubMed Web of Science ®Google Scholar
• Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I. S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 2009;1793:1008–1022.
   PubMed Web of Science ®Google Scholar
• Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417–429.
   PubMed Web of Science ®Google Scholar
• Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, Gazzolo D. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644–659.
   PubMed Web of Science ®Google Scholar
• Ikura M. Calcium binding and conformational response in EF-hand proteins. Trends Biochem Sci 1996;21:14–17.
   PubMed Web of Science ®Google Scholar
• Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003;21:97–108.
   PubMed Web of Science ®Google Scholar
• Heizmann CW. Ca2+-binding S100 proteins in the central nervous system. Neurochem Res 1999;24:1097–1100.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Lituania M, Bruschettini M, Ciotti S, Sacchi R, Serra G, Calevo MG et al. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 2005;38:229–233.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Monego G, Corvino V, Bruschettini M, Bruschettini P, Zelano G, Michetti F. Human milk contains S100B protein. Biochim Biophys Acta 2003;1619:209–212.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Michetti F. Perinatal S100B Protein Assessment in Human Unconventional Biological Fluids: A Minireview and New Perspectives. Cardiovasc Psychiatry Neurol 2010;2010:703563.
   PubMedGoogle Scholar
• Persson L, Hårdemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Påhlman S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911–918.
   PubMed Web of Science ®Google Scholar
• Lomas JP, Dunning J. Best evidence topic report. S-100b protein levels as a predictor for long-term disability after head injury. Emerg Med J 2005;22:889–891.
   PubMed Web of Science ®Google Scholar
• Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, Stevens GH et al. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2003;97:2806–2813.
   PubMed Web of Science ®Google Scholar
• Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T. S100B serum level predicts computed tomography findings after minor head injury. J Trauma 2007;62:1452–1456.
   PubMed Web of Science ®Google Scholar
• Springborg JB, Undén J, Ingebrigtsen T, Romner B. [Brain injury marker S100B can reduce the use of computer tomography in minor head injuries–secondary publication]. Ugeskr Laeg 2009;171:978–981.
   PubMedGoogle Scholar
• Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, Edwards M et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 2010;75:1786–1793.
   PubMed Web of Science ®Google Scholar
• Ekmektzoglou KA, Xanthos T, Papadimitriou L. Biochemical markers (NSE, S-100, IL-8) as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation. Resuscitation 2007;75:219–228.
   PubMed Web of Science ®Google Scholar
• Sedaghat F, Notopoulos A. S100 protein family and its application in clinical practice. Hippokratia 2008;12:198–204.
   PubMed Web of Science ®Google Scholar
• Yardan T, Erenler AK, Baydin A, Aydin K, Cokluk C. Usefulness of S100B protein in neurological disorders. J Pak Med Assoc 2011;61:276–281.
   PubMed Web of Science ®Google Scholar
• Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin Chem 2002;48:2097–2104.
   PubMed Web of Science ®Google Scholar
• Florio P, Michetti F, Bruschettini M, Lituania M, Bruschettini P, Severi FM, Petraglia F, Gazzolo D. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet 2004;364:270–272.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Bruschettini M, Lituania M, Serra G, Bonacci W, Michetti F. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 2001;47:1836–1838.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Di Iorio R, Marinoni E, Masetti P, Serra G, Giovannini L, Michetti F. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002;30:1356–1360.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M, Majewska U et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med 2003;157:1163–1168.
   PubMedGoogle Scholar
• Gazzolo D, Florio P, Ciotti S, Marinoni E, di Iorio R, Bruschettini M, Sacchi R et al. S100B protein in urine of preterm newborns with ominous outcome. Pediatr Res 2005;58:1170–1174.
   PubMed Web of Science ®Google Scholar
• Thorngren-Jerneck K, Alling C, Herbst A, Amer-Wahlin I, Marsal K. S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2004;55:406–412.
   PubMed Web of Science ®Google Scholar
• Blennow M, Sävman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 2001;90:1171–1175.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Frigiola A, Bashir M, Iskander I, Mufeed H, Aboulgar H, Venturini P et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS ONE 2009;4:e4298.
   PubMed Web of Science ®Google Scholar
• Giuseppe D, Sergio C, Pasqua B, Giovanni LV, Salvatore C, Frigiola A, Petra H, Maurizio A. Perinatal asphyxia in preterm neonates leads to serum changes in protein S-100 and neuron specific enolase. Curr Neurovasc Res 2009;6:110–116.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M, Majewska U et al. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 2004;32:131–136.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhou HY, Feng ZW, He L, Su ZY. [Urinary S100B protein and lactate/creatinine ratio measurements: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy]. Zhonghua Er Ke Za Zhi 2005;43:564–567.
   PubMedGoogle Scholar
• Murabayashi M, Minato M, Okuhata Y, Makimoto M, Hosono S, Masaoka N, Okada T et al. Kinetics of serum S100B in newborns with intracranial lesions. Pediatr Int 2008;50:17–22.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Vinesi P, Bartocci M, Geloso MC, Bonacci W, Serra G, Haglid KG, Michetti F. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 1999;170:32–35.
   PubMed Web of Science ®Google Scholar
• Loukovaara M, Teramo K, Alfthan H, Hämäläinen E, Stefanovic V, Andersson S. Amniotic fluid S100B protein and erythropoietin in pregnancies at risk for fetal hypoxia. Eur J Obstet Gynecol Reprod Biol 2009;142:115–118.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Marinoni E, di Iorio R, Lituania M, Bruschettini PL, Michetti F. Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr Res 2002;51:215–219.
   PubMed Web of Science ®Google Scholar
• Torrance HL, Benders MJ, Derks JB, Rademaker CM, Bos AF, Van Den Berg P, Longini M et al. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009;124:350–357.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Kornacka M, Bruschettini M, Lituania M, Giovannini L, Serra G, Majewska U, Michetti F. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem 2003;49:1215–1218.
   PubMed Web of Science ®Google Scholar
• Gazzolo D, Bruschettini M, Di Iorio R, Marinoni E, Lituania M, Marras M, Sarli R et al. Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses. Clin Chem 2002;48:647–650.
   PubMed Web of Science ®Google Scholar
• Akbari HM, Whitaker-Azmitia PM, Azmitia EC. Prenatal cocaine decreases the trophic factor S-100 beta and induced microcephaly: reversal by postnatal 5-HT1A receptor agonist. Neurosci Lett 1994;170:141–144.
   PubMed Web of Science ®Google Scholar
• Sandler SJ, Figaji AA, Adelson PD. Clinical applications of biomarkers in pediatric traumatic brain injury. Childs Nerv Syst 2010;26:205–213.
   PubMed Web of Science ®Google Scholar
• Nagdyman N, Grimmer I, Scholz T, Muller C, Obladen M. Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr Res 2003;54:270–275.
   PubMed Web of Science ®Google Scholar
• Nagdyman N, Kömen W, Ko HK, Müller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 2001;49:502–506.
   PubMed Web of Science ®Google Scholar
• Undén J, Romner B. A new objective method for CT triage after minor head injury–serum S100B. Scand J Clin Lab Invest 2009;69:13–17.
   PubMed Web of Science ®Google Scholar
• Romner B, Ingebrigtsen T, Kongstad P, Børgesen SE. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 2000;17:641–647.
   PubMed Web of Science ®Google Scholar
• Lo TY, Jones PA, Minns RA. Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins. J Neurotrauma 2009;26:1479–1487.
   PubMed Web of Science ®Google Scholar
• Liu L, Zheng CX, Peng SF, Zhou HY, Su ZY, He L, Ai T. Evaluation of urinary S100B protein level and lactate/creatinine ratio for early diagnosis and prognostic prediction of neonatal hypoxic-ischemic encephalopathy. Neonatology 2010;97:41–44.
   PubMed Web of Science ®Google Scholar
• Celtik C, Acunas B, Oner N, Pala O. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev 2004;26:398–402.
   PubMed Web of Science ®Google Scholar
• Sannia A, Zimmermann LJ, Gavilanes AW, Vles HJ, Serpero LD, Frulio R, Michetti F, Gazzolo D. S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta 2011;412:1337–1340.
   PubMed Web of Science ®Google Scholar